Epstein David C MD Rochester, NY - 14610

Epstein David C MD is categorized under Hospital, Professional Nursing School in Rochester, NY and active since 2002.

Epstein David C MD was established in 2002, and today employs 1 to 4, earning $500.000 to $999.999 per year. This is a Hospital, Professional Nursing School business, which does work in the B2C market, and is classified as a Hospital, Professional Nursing School, under code number 6211110 by the NAICS.

If you are seeking more information, feel free to contact David Epstein at the company’s single location by writing to 333 Humboldt St, Rochester, New York NY 14610 or by phoning (585) 922-1400. You can also visit this business on Facebook by going to their profile page at Facebook or on find them on Twitter.

Business Name: Epstein David C MD
Contact Person: David Epstein
Address: 333 Humboldt St, Rochester, New York 14610
Phone Number: (585) 922-1400
Website Address: rochestergeneral.org
Annual Revenue (USD): $500.000 to $999.999
Founded: 2002
Location Type: Single Location
Employee Number: 1 to 4
Business Type: B2C (Business to Consumer)
Business Category: Hospital, Professional Nursing School
SIC Code: 8062
NAICS Code: 6211110
Share This Business:

Epstein David C MD was started in 2002 to provide professional Hospital, Professional Nursing School under the SIC code 8062 and NAICS code 6211110. Since its inception, the company has gone on to take a total of 1 to 4 personnel under its employment and has achieved earnings of $500.000 to $999.999 per annum.

Feel free to contact David Epstein for inquiries that concern Epstein David C MD by calling the company number (585) 922-1400, as your correspondence is most welcome. Additionally, the physical location of the single location of Epstein David C MD can be found at the coordinates 43.15372,-77.55954 as well as the street address 333 Humboldt St in Rochester, New York 14610.

For its online presence, you may visit Epstein David C MD’s website at rochestergeneral.org and engage with its social media outlets through on Twitter and on Facebook.